DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML in Canada?
Not currently. The most recent shortage report for DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML is marked resolved (last updated October 5, 2026).
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
00664227
Strength
4MG
Dosage Form
SOLUTION
Route
INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR
Active Ingredient
DEXAMETHASONE PHOSPHATE
Tier
Tier 3 — Critical
Last Updated
2026-10-05
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Past Reports for This Drug
DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759